Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer Xenografts
- 1 April 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (7), 1091-1097
- https://doi.org/10.1016/s0006-2952(97)00682-5
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Association of intratumoral pharmacokinetics of fluorouracil with clinical responseThe Lancet, 1994
- Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Synthesis of 5-fluorouridine 5′-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin—II. Correlation between the tumor levels of the enzyme and the 5-fluorouracil-promoted increase in survival of tumor-bearing miceBiochemical Pharmacology, 1969